Down syndrome, autoimmunity and T regulatory cells
Open Access
- 10 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 169 (3) , 238-243
Abstract
Autoimmune diseases are more represented in Down syndrome (DS) individuals compared to chromosomally normal people. Natural T regulatory cells (nTreg) have been considered to be primary in the role of controlling the intensity and targets of the immune response. We have investigated the phenotypical and functional alteration of nTreg in a group of DS people. The phenotypical characteristic of Treg cells of 29 DS was analysed and compared with an age-matched healthy control group. The inhibitory potential of CD4+CD25highCD127low T regulatory cells was evaluated on autologous CD4+CD25- T cell proliferation in response to activation with a mytogenic pan-stimulus (anti-CD2, anti-CD3 and anti-CD28 antibodies). The CD4+CD25high cells in the DS and control groups were 2·692 ± 0·3808%, n = 29 and 1·246 ± 0·119, n = 29%, respectively (P = 0.0007), with a percentage of forkhead box protein 3 (FoxP3)-expressing cells of 79·21 ± 3·376%, n = 29 and 59·75 ± 4·496%, respectively (P = 0.0015). CD4+CD25+FoxP3+ cells were increased in peripheral blood from DS subjects (DS mean 5·231 ± 0·6065% n = 29, control mean 3·076 ± 0·3140% n = 29). The majority of CD4+CD25high were CD127low and expressed a high percentage of FoxP3 (natural Treg phenotype). While the proliferative capacity of DS T cells was not altered significantly compared to normal individuals, a reduced inhibitory potential of Treg compared to healthy controls was clearly observed (mean healthy control inhibition in Teff : Treg 1:1 co-culture: 58·9% ± 4·157%, n = 10 versus mean DS inhibition in Teff : Treg 1:1 co-culture: 39·8 ± 4·788%, n = 10, P = 0.0075; mean healthy control inhibition in Teff : Treg 1:0·5 co-culture: 45·10 ± 5·858%, n = 10 versus DS inhibition in Teff : Treg 1:0·5 co-culture: 24·10 ± 5·517%, n = 10, P = 0.0177). DS people present an over-expressed peripheral nTreg population with a defective inhibitory activity that may partially explain the increased frequency of autoimmune disease.Keywords
This publication has 44 references indexed in Scilit:
- A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor DiversityImmunity, 2011
- Infections and immunodeficiency in Down syndromeClinical and Experimental Immunology, 2011
- Phenotypical and functional specialization of FOXP3+ regulatory T cellsNature Reviews Immunology, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- Analysis of Interleukin-21-Induced Prdm1 Gene Regulation Reveals Functional Cooperation of STAT3 and IRF4 Transcription FactorsImmunity, 2009
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responsesNature, 2009
- Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21European Journal of Human Genetics, 2008
- TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic isletsJournal of Experimental Medicine, 2007
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006